Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth
Open Access
- 1 January 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (2) , 1209-1215
- https://doi.org/10.1074/jbc.275.2.1209
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- VEGF Prevents Apoptosis of Human Microvascular Endothelial Cells via Opposing Effects on MAPK/ERK and SAPK/JNK SignalingExperimental Cell Research, 1999
- Antiangiogenic Activity of Restin, NC10 Domain of Human Collagen XV: Comparison to EndostatinBiochemical and Biophysical Research Communications, 1999
- Macromolecular organization of basement membranesCurrent Opinion in Cell Biology, 1996
- COLLAGENS: Molecular Biology, Diseases, and Potentials for TherapyAnnual Review of Biochemistry, 1995
- Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin.The Journal of cell biology, 1994
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor propertiesKidney International, 1993
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Identification of a multifunctional, cell-binding peptide sequence from the a1(NC1) of type IV collagen.The Journal of cell biology, 1990
- Endothelial cell-matrix interactions: in vitro models of angiogenesis.Journal of Histochemistry & Cytochemistry, 1986